Pre-treatment serum vascular endothelial growth factor is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab

Jianda Yuan; Jun Zhou; Zhiwan Dong; Sapna Tandon; Deborah Kuk; Katherine S Panageas; Philip Wong; Jedd D Wolchok; F Stephen Hodi

doi:10.1186/2051-1426-1-S1-P247

Article info

Poster Presentation

Pre-treatment serum vascular endothelial growth factor is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab

Free

Authors

Jianda Yuan Ludwig Center for Cancer ImmunotherapyMemorial Sloan-Kettering Cancer Center New York NY USA PubMed articles Google scholar articles
Jun Zhou Department of Medical Oncology, Center for Immuno-oncologyDana-Farber Cancer Institute and Harvard Medical School Boston MA USA PubMed articles Google scholar articles
Zhiwan Dong Ludwig Center for Cancer ImmunotherapyMemorial Sloan-Kettering Cancer Center New York NY USA PubMed articles Google scholar articles
Sapna Tandon Ludwig Center for Cancer ImmunotherapyMemorial Sloan-Kettering Cancer Center New York NY USA PubMed articles Google scholar articles
Deborah Kuk Department of Epidemiology and BiostatisticMemorial Sloan-Kettering Cancer Center New York NY USA PubMed articles Google scholar articles
Katherine S Panageas Department of Epidemiology and BiostatisticMemorial Sloan-Kettering Cancer Center New York NY USA PubMed articles Google scholar articles
Philip Wong Ludwig Center for Cancer ImmunotherapyMemorial Sloan-Kettering Cancer Center New York NY USA PubMed articles Google scholar articles
Jedd D Wolchok Ludwig Center for Cancer ImmunotherapyMemorial Sloan-Kettering Cancer Center New York NY USA Department of MedicineMemorial Sloan-Kettering Cancer Center New York NY USA Weill Cornell Medical College of Cornell University New York NY USA PubMed articles Google scholar articles
F Stephen Hodi Department of Medical Oncology, Center for Immuno-oncologyDana-Farber Cancer Institute and Harvard Medical School Boston MA USA PubMed articles Google scholar articles

Citation

Yuan J, Zhou J, Dong Z, et al

Pre-treatment serum vascular endothelial growth factor is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab

Journal for ImmunoTherapy of Cancer 2013;1:P247. doi: 10.1186/2051-1426-1-S1-P247

Publication history

First published November 7, 2013.

Online issue publication

March 11, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password